Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies.

Document Type

Journal Article

Publication Date

4-23-2019

Journal

Ocular immunology and inflammation

DOI

10.1080/09273948.2019.1583347

Peer Reviewed

1

This document is currently not available here.

Share

COinS